IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,867 | -15.9% | 17,950 | 0.0% | 0.07% | -18.1% |
| Q2 2023 | $338,717 | +391.4% | 17,950 | 0.0% | 0.08% | +361.1% |
| Q1 2023 | $68,928 | -22.6% | 17,950 | 0.0% | 0.02% | -30.8% |
| Q4 2022 | $89,032 | +3.5% | 17,950 | 0.0% | 0.03% | -3.7% |
| Q3 2022 | $86,000 | +6.2% | 17,950 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $81,000 | -4.7% | 17,950 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $85,000 | -24.8% | 17,950 | +18.1% | 0.02% | -29.4% |
| Q4 2021 | $113,000 | +31.4% | 15,200 | 0.0% | 0.03% | +17.2% |
| Q3 2021 | $86,000 | -14.0% | 15,200 | 0.0% | 0.03% | -14.7% |
| Q2 2021 | $100,000 | -18.7% | 15,200 | 0.0% | 0.03% | -30.6% |
| Q1 2021 | $123,000 | +25.5% | 15,200 | 0.0% | 0.05% | +19.5% |
| Q4 2020 | $98,000 | +78.2% | 15,200 | 0.0% | 0.04% | +51.9% |
| Q3 2020 | $55,000 | – | 15,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
| QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
| Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
| Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
| PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
| Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
| Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
| DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
| DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |